Our partner is a fully integrated pre-IPO global biopharmaceutical organization focused on the development and manufacturing of first-in-class biosimilar medicines. They operate on the principle that if there's a cure, it should be accessible to everyone.

This critical hire sat within a product-facing position that provided best-in-class CMC strategy for assigned products which ensured the development, licensure, and maintenance of the product on the market. This role focused on life-cycle regulatory maintenance for to-be launched and licensed products, inclusive of assessing worldwide regulatory impact from changes, as well as authoring worldwide CMC submissions.